DaVita
DVA
#1545
Rank
NZ$25.16 B
Marketcap
NZ$392.12
Share price
1.27%
Change (1 day)
67.94%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$18.80

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$19.39. In 2025 the company made an earnings per share (EPS) of NZ$17.84 a decrease over its 2024 EPS that were of NZ$19.44.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$18.805.39%
2025NZ$17.84-8.25%
2024NZ$19.4444.94%
2023NZ$13.4127.26%
2022NZ$10.54-35.56%
2021NZ$16.3644.1%
2020NZ$11.3519.7%
2019NZ$9.48540.48%
2018NZ$1.48-76.07%
2017NZ$6.19-19.31%
2016NZ$7.67242.52%
2015NZ$2.24-62.87%
2014NZ$6.0313.43%
2013NZ$5.318.45%
2012NZ$4.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$42.85 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$20.02 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$34.28 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.40-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA